Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder

被引:436
|
作者
Rajkowska, G
Halaris, A
Selemon, LD
机构
[1] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Lab Quantitat Neuroanat, Jackson, MS 39216 USA
[2] Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA
关键词
postmortem; schizophrenia; mood disorders; human; frontal carter; morphometry;
D O I
10.1016/S0006-3223(01)01080-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Bipolar disorder (BPD) is a mental illness in which depression and mania typically alternate, and both phases can present with psychotic features. The symptomatology of BPD, therefore, resembles major depressive disorder (MDD) and schizophrenia (SCHZ), posing diagnostic dilemmas. Distinct alterations in cellular architecture of the dorsolateral prefrontal cortex distinguish SCHZ and MDD, whereas the cellular neuropathology of BPD has not been studied. Methods: Dorsolateral prefrontal area 9 was analyzed using a three-dimensional morphometric method in postmortem brains from 10 BPD patients anti II matched nonpsychiatric control subjects. Results: Area 9 in BPD was characterized by, reduced neuronal density in layer III (16%-22%) and reduced pyramidal cell density in layers III and V (17%-30%). A 19% reduction in glial density tt was found in sublayer IIIc coupled with enlargement and changes in shape of glial nuclei spanning multiple layers. Conclusions: The morphologic signature of BPD, i.e,, decreased neuronal and glial density in association with glial hypertrophy, is distinct from previously described elevations in neuronal density in SCHZ, instead resembling the reductions in cell density found in MDD. Thus, the neuropathologic distinctions between BPD and SCHZ al e indicative of separate mental illnesses, each with a unique morphologic disturbance of specific neural circuits. (C) 2001 Society of Biological Psychiatry.
引用
收藏
页码:741 / 752
页数:12
相关论文
共 50 条
  • [31] Density of Somatostatin Neurons in the Dorsolateral Prefrontal Cortex of Schizophrenia Subjects
    Dienel, Samuel
    Fish, Kenneth
    Lewis, David
    BIOLOGICAL PSYCHIATRY, 2021, 89 (09) : S145 - S145
  • [32] GABA-RELATED MRNA EXPRESSION IN THE DORSOLATERAL PREFRONTAL CORTEX (DLPFC) OF SUBJECTS WITH BIPOLAR OR MAJOR DEPRESSIVE DISORDER
    Morris, Harvey M.
    Lewis, D. A.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 231 - 232
  • [33] Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression
    Regenold, William T.
    Phatak, Pornima
    Marano, Christopher M.
    Gearhart, Lorle
    Viens, Claudia H.
    Hisley, K. Calvin
    PSYCHIATRY RESEARCH, 2007, 151 (03) : 179 - 188
  • [34] Proteomic analysis of deep white matter from the dorsolateral prefrontal cortex in schizophrenia (SCZ) and bipolar disorder (BPD)
    English, J
    Dunn, M
    Cotter, DR
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 210 - 210
  • [35] Label-free proteomics differences in the dorsolateral prefrontal cortex between bipolar disorder patients with and without psychosis
    Ho, Ada M-C
    Cabello-Arreola, Alejandra
    Markota, Matej
    Heppelmann, Carrie J.
    Charlesworth, M. Cristine
    Ozerdem, Aysegul
    Mahajan, Gouri
    Rajkowska, Grazyna
    Stockmeier, Craig A.
    Frye, Mark A.
    Choi, Doo-Sup
    Veldic, Marin
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 270 : 165 - 173
  • [36] Decreased Expression of Sprouty2 in the Dorsolateral Prefrontal Cortex in Schizophrenia and Bipolar Disorder: A Correlation with BDNF Expression
    Pillai, Anilkumar
    PLOS ONE, 2008, 3 (03):
  • [37] Adding Sarcosine to Antipsychotic Treatment in Patients with Stable Schizophrenia Changes the Concentrations of Neuronal and Glial Metabolites in the Left Dorsolateral Prefrontal Cortex
    Strzelecki, Dominik
    Podgorski, Michal
    Kaluzynska, Olga
    Stefanczyk, Ludomir
    Kotlicka-Antczak, Magdalena
    Gmitrowicz, Agnieszka
    Grzelak, Piotr
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (10) : 24475 - 24489
  • [38] Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder
    Winsberg, ME
    Sachs, N
    Tate, DL
    Dunai, M
    Strong, CM
    Spielman, DM
    Ketter, TA
    BIOLOGICAL PSYCHIATRY, 1998, 43 : 23S - 23S
  • [39] Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder
    Winsberg, ME
    Sachs, N
    Tate, DL
    Adalsteinsson, E
    Spielman, D
    Ketter, TA
    BIOLOGICAL PSYCHIATRY, 2000, 47 (06) : 475 - 481
  • [40] Glutamatergic abnormalities in dorsolateral prefrontal cortex of patients with major depressive disorder
    Nery, FG
    Stanley, JA
    Chen, HH
    Nicoletti, M
    Hatch, JP
    Monkul, ES
    Caetano, SC
    Sanches, M
    Najt, P
    Peluso, M
    Silva, LP
    Ortiz, O
    Soares, JC
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 155S - 156S